Asthmapolis is all fired up after getting clearance from the U.S. Food and Drug Administration in early July to market its high-tech asthma-tracking device.
“It’s very, very exciting. There’s a super-positive, wonderful energy around the office every day,” said Inger Couture, chief regulatory officer.
The young company, established in 2010 based on the work of co-founder David Van Sickle, an asthma epidemiologist and honorary associate fellow at the UW-Madison, already has moved to bigger quarters at 612 W. Main St. from its previous offices at 3 S. Pinckney St.
Couture, hired one year ago, was Asthmapolis’ first employee. Today the company has 13 full-time and part-time staffers and is looking to hire at least six people in the short-term. “We have ads on Twitter and … everywhere that I can think of,” Couture said.